Contribution of type III interferons to antiviral immunity: Location, location, location

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

Type I interferons (IFN-α/β) and the more recently identified type III IFNs (IFN-λ) function as the first line of defense against virus infection and regulate the development of both innate and adaptive immune responses. Type III IFNs were originally identified as a novel ligand-receptor system acting in parallel with type I IFNs, but subsequent studies have provided increasing evidence for distinct roles for each IFN family. In addition to their compartmentalized antiviral actions, these two systems appear to have multiple levels of cross-regulation and act coordinately to achieve effective antimicrobial protection with minimal collateral damage to the host.

Original languageEnglish (US)
Pages (from-to)7295-7303
Number of pages9
JournalJournal of Biological Chemistry
Volume292
Issue number18
DOIs
StatePublished - May 5 2017

Fingerprint

Interferon Type I
Adaptive Immunity
Virus Diseases
Viruses
Innate Immunity
Interferons
Antiviral Agents
Immunity
Ligands

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{213d63a96b2246be8f9a81f37e385e8e,
title = "Contribution of type III interferons to antiviral immunity: Location, location, location",
abstract = "Type I interferons (IFN-α/β) and the more recently identified type III IFNs (IFN-λ) function as the first line of defense against virus infection and regulate the development of both innate and adaptive immune responses. Type III IFNs were originally identified as a novel ligand-receptor system acting in parallel with type I IFNs, but subsequent studies have provided increasing evidence for distinct roles for each IFN family. In addition to their compartmentalized antiviral actions, these two systems appear to have multiple levels of cross-regulation and act coordinately to achieve effective antimicrobial protection with minimal collateral damage to the host.",
author = "Sergei Kotenko and Joan Durbin",
year = "2017",
month = "5",
day = "5",
doi = "10.1074/jbc.R117.777102",
language = "English (US)",
volume = "292",
pages = "7295--7303",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "18",

}

Contribution of type III interferons to antiviral immunity : Location, location, location. / Kotenko, Sergei; Durbin, Joan.

In: Journal of Biological Chemistry, Vol. 292, No. 18, 05.05.2017, p. 7295-7303.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Contribution of type III interferons to antiviral immunity

T2 - Location, location, location

AU - Kotenko, Sergei

AU - Durbin, Joan

PY - 2017/5/5

Y1 - 2017/5/5

N2 - Type I interferons (IFN-α/β) and the more recently identified type III IFNs (IFN-λ) function as the first line of defense against virus infection and regulate the development of both innate and adaptive immune responses. Type III IFNs were originally identified as a novel ligand-receptor system acting in parallel with type I IFNs, but subsequent studies have provided increasing evidence for distinct roles for each IFN family. In addition to their compartmentalized antiviral actions, these two systems appear to have multiple levels of cross-regulation and act coordinately to achieve effective antimicrobial protection with minimal collateral damage to the host.

AB - Type I interferons (IFN-α/β) and the more recently identified type III IFNs (IFN-λ) function as the first line of defense against virus infection and regulate the development of both innate and adaptive immune responses. Type III IFNs were originally identified as a novel ligand-receptor system acting in parallel with type I IFNs, but subsequent studies have provided increasing evidence for distinct roles for each IFN family. In addition to their compartmentalized antiviral actions, these two systems appear to have multiple levels of cross-regulation and act coordinately to achieve effective antimicrobial protection with minimal collateral damage to the host.

UR - http://www.scopus.com/inward/record.url?scp=85018378564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018378564&partnerID=8YFLogxK

U2 - 10.1074/jbc.R117.777102

DO - 10.1074/jbc.R117.777102

M3 - Review article

C2 - 28289095

AN - SCOPUS:85018378564

VL - 292

SP - 7295

EP - 7303

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 18

ER -